Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non–small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing
Year: 2024
Type: article
Author: Jay M. Lee
Institution: University of California, Los Angeles
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4394989739